INTL MEDICATION FDA Approval ANDA 062325

ANDA 062325

INTL MEDICATION

FDA Drug Application

Application #062325

Application Sponsors

ANDA 062325INTL MEDICATION

Marketing Status

Discontinued001
Discontinued003
Discontinued004

Application Products

001INJECTABLE;INJECTIONEQ 40MG BASE/ML0GENTAMICINGENTAMICIN SULFATE
003INJECTABLE;INJECTIONEQ 1MG BASE/ML0GENTAMICINGENTAMICIN SULFATE
004INJECTABLE;INJECTIONEQ 100MG BASE/100ML0GENTAMICINGENTAMICIN SULFATE

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62325
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.